{"id":{"repo_id":"glasgow","oai_identifier":"oai:theses.gla.ac.uk:3784"},"canonical_url":"https://search.ndltd.org/etd/glasgow/oai:theses.gla.ac.uk:3784","repository":{"repo_id":"glasgow","name":"University of Glasgow","base_url":"https://theses.gla.ac.uk/cgi/oai2"},"display":{"title":"Studies of the G protein beta 3 subunit in human hypertension","abstract":"I have studied the GNB3 gene as a candidate gene for hypertension and left ventricular mass in a systematic and comprehensive manner. I have carried out association studies in three independent populations - A case-control study with well characterised hypertensive and their matched controls; a twin study looking at echocardiographic LV mass; and a large family based study analysing blood pressure and ECG LV mass. In addition I have also looked at three additional candidate genes including ACE, aldosterone synthase and beta-1 adrenoceptor. Though these studies concluded that there was no association between the C825T polymorphism and blood pressure or LV mass, I have demonstrated a significant heritability of various electrocardiographic measures of LV mass and an interaction between GNB3, ACE and SF1 explaining the variability of continuous measures of LV mass in this population. I studied the functional aspects of the GNB3 polymorphism by measuring platelet aggregation in normal human volunteers, using it as a marker of G-protein related signal transduction. However, there was also no association between epinephrine or platelet activating factor induced platelet aggregation and the GNB3 genotype. Finally, I performed molecular studies using cells transfected with b3 (wild-type) and b3-s (splice-variant) of GNB3 along with a fusion construct of a2AGi, and measuring of GTPase activity and calcium signalling. There was no significant difference between b3 or b3-s transfected cells, in terms of epinephrine stimulated GTPase activity, onset-delay of calcium release and time-to-peak of calcium signal. However, cells expressing b3-s showed a significantly lower rate of calcium release compared to cells expressing b3. These results indicate that the G protein b3-s subunit has no functional difference or possible slightly reduced effect compared to the wild type.","abstract_html":"I have studied the GNB3 gene as a candidate gene for hypertension and left ventricular mass in a systematic and comprehensive manner. I have carried out association studies in three independent populations - A case-control study with well characterised hypertensive and their matched controls; a twin study looking at echocardiographic LV mass; and a large family based study analysing blood pressure and ECG LV mass. In addition I have also looked at three additional candidate genes including ACE, aldosterone synthase and beta-1 adrenoceptor. Though these studies concluded that there was no association between the C825T polymorphism and blood pressure or LV mass, I have demonstrated a significant heritability of various electrocardiographic measures of LV mass and an interaction between GNB3, ACE and SF1 explaining the variability of continuous measures of LV mass in this population. I studied the functional aspects of the GNB3 polymorphism by measuring platelet aggregation in normal human volunteers, using it as a marker of G-protein related signal transduction. However, there was also no association between epinephrine or platelet activating factor induced platelet aggregation and the GNB3 genotype. Finally, I performed molecular studies using cells transfected with b3 (wild-type) and b3-s (splice-variant) of GNB3 along with a fusion construct of a2AGi, and measuring of GTPase activity and calcium signalling. There was no significant difference between b3 or b3-s transfected cells, in terms of epinephrine stimulated GTPase activity, onset-delay of calcium release and time-to-peak of calcium signal. However, cells expressing b3-s showed a significantly lower rate of calcium release compared to cells expressing b3. These results indicate that the G protein b3-s subunit has no functional difference or possible slightly reduced effect compared to the wild type.","abstract_has_math":false,"creators":["Padmanabhan, Sandosh"],"institution":"University of Glasgow","degree_name":null,"degree_level":"PhD","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2004,"date_issued":"2004","date_published":"2004","updated_at":"2026-11-19T08:22:35Z","subjects":["R Medicine (General)"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"https://theses.gla.ac.uk/3784/1/2004PadmanabhanPhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://theses.gla.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Atheses.gla.ac.uk%3A3784","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Padmanabhan, Sandosh"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2004"]},{"key":"dc:date.issued","label":"Date","values":["2004"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Glasgow"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://theses.gla.ac.uk/3784/"]},{"key":"dc:relation.isreferencedby.uri","label":"Dc Relation Isreferencedby URI","values":["https://gla.on.worldcat.org/oclc/60775301"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["R Medicine (General)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://theses.gla.ac.uk/3784/1/2004PadmanabhanPhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["I have studied the GNB3 gene as a candidate gene for hypertension and left ventricular mass in a systematic and comprehensive manner. I have carried out association studies in three independent populations - A case-control study with well characterised hypertensive and their matched controls; a twin study looking at echocardiographic LV mass; and a large family based study analysing blood pressure and ECG LV mass. In addition I have also looked at three additional candidate genes including ACE, aldosterone synthase and beta-1 adrenoceptor. Though these studies concluded that there was no association between the C825T polymorphism and blood pressure or LV mass, I have demonstrated a significant heritability of various electrocardiographic measures of LV mass and an interaction between GNB3, ACE and SF1 explaining the variability of continuous measures of LV mass in this population. I studied the functional aspects of the GNB3 polymorphism by measuring platelet aggregation in normal human volunteers, using it as a marker of G-protein related signal transduction. However, there was also no association between epinephrine or platelet activating factor induced platelet aggregation and the GNB3 genotype. Finally, I performed molecular studies using cells transfected with b3 (wild-type) and b3-s (splice-variant) of GNB3 along with a fusion construct of a2AGi, and measuring of GTPase activity and calcium signalling. There was no significant difference between b3 or b3-s transfected cells, in terms of epinephrine stimulated GTPase activity, onset-delay of calcium release and time-to-peak of calcium signal. However, cells expressing b3-s showed a significantly lower rate of calcium release compared to cells expressing b3. These results indicate that the G protein b3-s subunit has no functional difference or possible slightly reduced effect compared to the wild type."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Studies of the G protein beta 3 subunit in human hypertension"]}]}],"canonical_facts":{"dc:creator":["Padmanabhan, Sandosh"],"dc:date":["2004"],"dc:date.issued":["2004"],"dc:description.abstract":["I have studied the GNB3 gene as a candidate gene for hypertension and left ventricular mass in a systematic and comprehensive manner. I have carried out association studies in three independent populations - A case-control study with well characterised hypertensive and their matched controls; a twin study looking at echocardiographic LV mass; and a large family based study analysing blood pressure and ECG LV mass. In addition I have also looked at three additional candidate genes including ACE, aldosterone synthase and beta-1 adrenoceptor. Though these studies concluded that there was no association between the C825T polymorphism and blood pressure or LV mass, I have demonstrated a significant heritability of various electrocardiographic measures of LV mass and an interaction between GNB3, ACE and SF1 explaining the variability of continuous measures of LV mass in this population. I studied the functional aspects of the GNB3 polymorphism by measuring platelet aggregation in normal human volunteers, using it as a marker of G-protein related signal transduction. However, there was also no association between epinephrine or platelet activating factor induced platelet aggregation and the GNB3 genotype. Finally, I performed molecular studies using cells transfected with b3 (wild-type) and b3-s (splice-variant) of GNB3 along with a fusion construct of a2AGi, and measuring of GTPase activity and calcium signalling. There was no significant difference between b3 or b3-s transfected cells, in terms of epinephrine stimulated GTPase activity, onset-delay of calcium release and time-to-peak of calcium signal. However, cells expressing b3-s showed a significantly lower rate of calcium release compared to cells expressing b3. These results indicate that the G protein b3-s subunit has no functional difference or possible slightly reduced effect compared to the wild type."],"dc:format":["application/pdf"],"dc:identifier.uri":["https://theses.gla.ac.uk/3784/1/2004PadmanabhanPhD.pdf"],"dc:language":["en"],"dc:publisher.institution":["University of Glasgow"],"dc:relation.isreferencedby":["https://theses.gla.ac.uk/3784/"],"dc:relation.isreferencedby.uri":["https://gla.on.worldcat.org/oclc/60775301"],"dc:subject":["R Medicine (General)"],"dcterms:accessrights":["public"],"dc:title":["Studies of the G protein beta 3 subunit in human hypertension"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["PhD"]},"updated_at":"2026-11-19T08:22:35Z"}